What Actually Happens in Month 2 on Wegovy

The myth: if the scales barely moved in month 2, the treatment isn't working

This is probably the most common worry our prescribers hear at the eight-week mark. The expectation (fuelled by before-and-after content online) is that dramatic changes should already be visible. The reality is more measured, and understanding why helps you stay the course.

The STEP 1 trial, published in the New England Journal of Medicine, followed adults on semaglutide 2.4 mg for 68 weeks and recorded an average weight reduction of around 15%. That figure accumulated gradually. The early weeks are largely about dose escalation and tolerance, not peak fat loss. At month 2 most people are still on 0.5 mg — well below the 2.4 mg maintenance dose that produces the headline results.

What month 2 is actually doing is setting up the conditions for later progress: your appetite is beginning to change, your relationship with portion sizes is shifting, and your body is adjusting to the medicine. The full Wegovy overview explains how semaglutide works across the whole treatment course.

A small number of people do see more noticeable early loss, individual response varies considerably. But if your clothes feel the same at week eight, that doesn't mean you're a non-responder. It means you're still climbing the dose ladder.

What the 0.5 mg dose actually feels like, and why side effects can spike here

The first month's 0.25 mg dose is explicitly a tolerability dose: its job is to let your digestive system adjust, not to suppress appetite meaningfully. Moving to 0.5 mg in month 2 is when most people notice semaglutide's effects for the first time. Food becomes less preoccupying. Portion sizes that felt normal now feel like too much. That's the GLP-1 receptor agonist mechanism in action, slowing gastric emptying and signalling fullness earlier.

The trade-off is that side effects can intensify at dose-increase weeks. Nausea is the most reported; others include constipation, loose stools, indigestion, and tiredness. NHS guidance on semaglutide describes these as typically mild to moderate and most prominent in the days after an injection, easing as the week progresses.

Practically: eating smaller amounts more slowly, avoiding very fatty or spicy meals around injection day, and keeping well hydrated all help. If nausea is severe or persistent, that's a conversation for your prescriber, dose timing or pace of escalation can sometimes be adjusted. Never alter your injection schedule without clinical input; your Patient Information Leaflet and prescriber are the right reference points for anything dose-related.

Most people find the worst of the side effects pass within a week or two of each increase. The Wegovy injection guide covers practical injection technique if you're also navigating the practicalities of the pen itself.

Building habits in month 2: why this window matters more than you might think

One thing the clinical evidence is consistent on: semaglutide works best alongside changes to diet and activity, not instead of them. Month 2 is a useful moment to lean into that, because appetite suppression is becoming real but weight loss hasn't yet plateaued, you're in a window where new patterns are easier to establish.

Protein adequacy matters particularly on GLP-1 medicines. When overall food intake falls, getting enough protein helps protect muscle mass. Fibre and hydration support the digestive side effects noted above. The NHS healthy weight guidance is a practical starting point for thinking about what to eat alongside treatment; your prescriber or a dietitian can personalise this.

It's also worth noting that the costs of private Wegovy treatment (which you can explore on our Wegovy cost page) are a real consideration for many people planning a multi-month course. Understanding the full picture early helps you plan.

If month 2 feels harder than you expected, that's a widely shared experience, and our guide to the first month on Wegovy is worth revisiting to see how far you've already come. What tends to change by month 3 is that the dose increases again, appetite suppression deepens, and for many people the scales start to reflect what the medicine has been quietly doing all along.

When to contact your prescriber during month 2

Most people get through the second month without needing urgent clinical input. But a few situations warrant a call rather than waiting it out.

Severe, persistent stomach pain (especially pain that radiates to the back) needs prompt medical assessment. This is the symptom pattern associated with acute pancreatitis, which the MHRA highlighted as a known, infrequent but serious risk in a Drug Safety Update issued in January 2026 for GLP-1 medicines. It's rare, but don't sit on it.

Signs of dehydration from sustained vomiting or diarrhoea, symptoms of an allergic reaction, or a significant low mood are also reasons to contact a clinician promptly. You can report any suspected side effects directly to the MHRA at the Yellow Card scheme.

For anything less acute (questions about your injection, concerns about whether you're responding, or wanting to discuss what month 4 might look like) our prescribers are available seven days a week. When you're ready to start a supervised course from the beginning, a free consultation is the first step.